# GHK-Cu vs minoxidil for hair: the evidence side by side

Source: https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [Recovery](https://pepvault.app/guides#recovery)

# GHK-Cu vs minoxidil for hair: the evidence side by side

Reviewed November 2026 22 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

GHK-Cu vs minoxidil for hair: the trials and FDA labels behind minoxidil, the small studies and lab work behind GHK-Cu, and what oral minoxidil adds.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 22
- **Questions:** 10
- **Compounds:** 1

## The short answer

Minoxidil has the trials. In a 48-week trial of 393 men, 5% minoxidil regrew more hair than 2% or placebo, women's trials found the same, and it is sold over the counter. GHK-Cu has no scalp hair-loss trial of its own and has never been tested against minoxidil in people. Its hair data are one small eyebrow trial, mixtures, cells and rodents.

Every number checked at its primary source · Nov 20, 2026 · [22 sources](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Minoxidil: large randomized placebo-controlled trials in men and women, and FDA over-the-counter approval. GHK-Cu for hair: one small eyebrow trial, combination products, and cell and rodent studies.

## Which has more evidence, GHK-Cu or minoxidil?

Minoxidil, by a wide margin. It has placebo-controlled trials with hundreds of men and women, and the FDA lets it be sold without a prescription[1](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-1) [2](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-2) [6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6). GHK-Cu, a copper peptide used in skin care, has been tested on its own on human hair once: on eyebrows, in 18 people[15](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-15).

| At a glance | Minoxidil on the scalp | GHK-Cu on the scalp |
| --- | --- | --- |
| What it is | A blood-pressure drug that regrows hair on the scalp[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [20](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-20) | Three amino acids holding a copper ion; a cosmetic ingredient |
| US status for hair loss | Approved over the counter: 2% and 5% solution, 5% foam[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7) [8](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-8) | Not approved for hair loss |
| Largest hair trial | 393 men, 48 weeks, against 2% and placebo[1](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-1) | 18 adults, eyebrows only, 12 weeks[15](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-15) |
| Trials in women | 381 women for 48 weeks; 404 women for 24 weeks[2](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-2) [4](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-4) | None on the scalp |
| Tested against the other | Not in people; once in mice[12](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-12) | Not in people; once in mice[12](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-12) |
| Common side effects | Itching, scalp irritation, unwanted facial hair[1](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-1) [2](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-2) [6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) | Few reported; no serious effects in the eyebrow trial[15](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-15) |
| When results show | From 2 to 4 months in men, 3 to 6 months in women on the foam, per the labels[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7) | No label; the eyebrow trial read its result at 12 weeks[15](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-15) |
| If you stop | Hair loss begins again, per the labels[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7) | Not studied |

Look at the colour first: almost all of GHK-Cu's hair evidence is below the line where people start.

GHK-Cu for skin, from the wrinkle trials to injection, has its own guide: pepvault.app/guides/ghk-cu-skin-and-hair.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's side-effects log keeps each entry with its date, severity and a note, so an itchy week or a shedding phase sits on the calendar beside your start date.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## How does each one work on the hair follicle?

A follicle cycles between a growth phase (anagen) and a resting phase (telogen). In pattern hair loss follicles shrink and the growth phase shortens, so hairs come back thinner.

Minoxidil pushes the other way. In animal studies it shortens the resting phase so follicles start growing sooner, and it may lengthen the growth phase and enlarge the follicle; it probably acts the same way in people[9](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-9). As a tablet it lowers blood pressure by opening potassium channels in blood vessel walls. Whether that channel explains the hair effect had not been shown when that 2004 review was written[9](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-9).

GHK-Cu is three amino acids, glycine, histidine and lysine, holding one copper ion. Its proposed hair action runs through the dermal papilla, the cells at the base of the follicle that steer its growth: a close relative, AHK-Cu, made those cells multiply and scalp follicles lengthen in a dish[10](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-10). That is tissue outside the body, not a person's scalp.

Minoxidil's effect is on timing and size: follicles start growing sooner and grow larger.

[Peptide Sky See GHK-Cu as a molecule 53 peptides as a night sky in 3D. Each star opens into its molecule, one bead per amino acid, with the measured shape where one exists. Open the Peptide Sky](https://pepvault.app/lab/sky)

## What did the minoxidil trials find?

Five randomized trials (pepvault.app/glossary/randomized-controlled-trial) carry most of the weight, counting hairs in a marked patch of scalp against a placebo (pepvault.app/glossary/placebo), the same liquid or foam without minoxidil, or the other strength.

| Trial | Who | What was compared | What they found |
| --- | --- | --- | --- |
| Olsen 2002[1](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-1) | 393 men aged 18 to 49, 48 weeks | 5% vs 2% solution vs placebo, twice daily | 5% beat 2% and placebo; 45% more regrowth than 2% at week 48 |
| Lucky 2004[2](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-2) | 381 women aged 18 to 49, 48 weeks | 5% vs 2% solution vs placebo, twice daily | Both strengths beat placebo on hair counts; 5% beat 2% only on the women's own rating of benefit |
| Olsen 2007[3](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-3) | 352 men aged 18 to 49, 16 weeks | 5% foam vs placebo foam | More hair on the foam (p < 0.0001) |
| Bergfeld 2016[4](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-4) | 404 women, 24 weeks | 5% foam once daily vs placebo foam | 9.1 more hairs per square centimetre than placebo at week 24 |
| Blume-Peytavi 2016[5](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-5) | 322 women, read at 24 weeks | 5% foam once daily vs 2% solution twice daily | About 24 more hairs per square centimetre than at the start, on each; the test for 'no worse' missed its preset bar |

The labels put it plainly. On the men's 5% products, results may show at 2 months or take 4, and they are for the top of the scalp, not a receding hairline[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6). On the women's once-a-day 5% foam, results may show at 3 months or take 6[7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7). The women's 2% label: after 8 months, 19% of women reported moderate regrowth, against 7% on placebo[8](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-8). Every label says regrowth lasts only with continued use[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7) [8](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-8).

## With this guide

### GHK-Cu

- [GHK-Cu: the full reference](https://pepvault.app/peptides/ghk-cu)
- [GHK-Cu dose guide](https://pepvault.app/lab/dosage/ghk-cu)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ghk-cu-10mg)
- [50 mg vial](https://pepvault.app/tools/reconstitution-calculator/ghk-cu-50mg)
- [100 mg vial](https://pepvault.app/tools/reconstitution-calculator/ghk-cu-100mg)

### Studies

- [GHK-Cu: no faster redness fading after CO2 laser skin resurfacing](https://pepvault.app/research/ghk-cu-miller-2006)
- [GHK-Cu gel: 98.5% median closure of diabetic plantar ulcers vs 60.8%](https://pepvault.app/research/ghk-cu-mulder-1994)
- [GHK-Cu: review of 20 studies finds skin repair signals, few trials](https://pepvault.app/research/ghk-cu-mokhtar-2026)
- [All 11 studies](https://pepvault.app/research#ghk-cu)

### Compared with

- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [TB-500 vs GHK-Cu](https://pepvault.app/peptides/compare/tb-500-vs-ghk-cu)
- [GHK-Cu vs KPV](https://pepvault.app/peptides/compare/ghk-cu-vs-kpv)
- [GHK-Cu vs SNAP-8](https://pepvault.app/peptides/compare/ghk-cu-vs-snap-8)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Skin and longevity path

- [GHK-Cu for skin and hair: what's measured](https://pepvault.app/guides/ghk-cu-skin-and-hair)
- [Melanotan 1 vs 2: what each one does](https://pepvault.app/guides/melanotan-1-vs-melanotan-2)
- [What is Cerebrolysin? The trial evidence](https://pepvault.app/guides/cerebrolysin-explained)
- [Khavinson bioregulators, explained](https://pepvault.app/guides/khavinson-bioregulators-explained)
- [SS-31 (elamipretide): what the trials show](https://pepvault.app/guides/ss-31-elamipretide)
- [MOTS-c: the mouse and human studies](https://pepvault.app/guides/mots-c-studies)
- [SS-31 vs MOTS-c: where each works and what the human data show](https://pepvault.app/guides/ss-31-vs-mots-c)
- [Are collagen peptides the same as research peptides?](https://pepvault.app/guides/collagen-vs-research-peptides)
- [GHK-Cu injection vs topical: what the studies show](https://pepvault.app/guides/ghk-cu-injection-vs-topical)
- [Thymulin vs Thymalin: what's the difference?](https://pepvault.app/guides/thymulin-vs-thymalin)
- [Semax and Selank: what the studies found](https://pepvault.app/guides/semax-and-selank)
- [PT-141 (bremelanotide) for women and men: what the trials measured](https://pepvault.app/guides/pt-141-bremelanotide)
- [PT-141 nasal spray: does it work?](https://pepvault.app/guides/pt-141-nasal-spray)
- [How to reconstitute NAD+, and how often the studies gave it](https://pepvault.app/guides/nad-plus-mixing-and-how-often)
- [The FDA peptide panel explained: both meetings and what each vote means](https://pepvault.app/guides/fda-peptide-panel-explained)
- [Low-dose naltrexone (LDN): what it's used for and what the trials show](https://pepvault.app/guides/low-dose-naltrexone)
- [Is low-dose naltrexone (LDN) safe in pregnancy, and before trying to conceive?](https://pepvault.app/guides/ldn-and-pregnancy)
- [Do you stop low-dose naltrexone (LDN) before surgery or a colonoscopy?](https://pepvault.app/guides/ldn-before-surgery)
- [Does minoxidil cause hair loss?](https://pepvault.app/guides/minoxidil-shedding)
- [Can you take minoxidil with finasteride?](https://pepvault.app/guides/minoxidil-with-finasteride)
- [Peptides for hair growth: what the studies show](https://pepvault.app/guides/peptides-for-hair-growth)
- [Peptides for skin: what the human studies show](https://pepvault.app/guides/peptides-for-skin)
- [Do tanning peptides protect you from the sun?](https://pepvault.app/guides/tanning-peptides-and-the-sun)
- [Tretinoin vs retinol vs GHK-Cu for skin](https://pepvault.app/guides/tretinoin-vs-retinol-vs-ghk-cu)
- [Epitalon and telomeres: what was measured](https://pepvault.app/guides/epitalon-and-telomeres)
- [Dihexa: what is known, and what is not](https://pepvault.app/guides/dihexa-what-is-known)
- [Does Pinealon help sleep, and why does it make some people sleepy?](https://pepvault.app/guides/pinealon-and-sleep)
- [Selank vs oxytocin for anxiety: what the trials found](https://pepvault.app/guides/selank-vs-oxytocin-for-anxiety)
- [Oxytocin nasal spray: what it is used for](https://pepvault.app/guides/oxytocin-nasal-spray)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Cycle](https://pepvault.app/glossary/cycle)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Boxed warning](https://pepvault.app/glossary/boxed-warning)
- [Double-blind](https://pepvault.app/glossary/double-blind)

## What is the hair evidence for GHK-Cu?

Only the first of these tested GHK-Cu itself on people. Read the third column first.

| Study | What was tested | Who or what | What they found |
| --- | --- | --- | --- |
| Bo 2026[15](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-15) | 2% GHK-Cu serum on one eyebrow, placebo serum on the other, twice daily | 18 healthy adults aged 18 to 40, 12 weeks | More and thicker eyebrow hairs on the GHK-Cu side; no serious side effects |
| Lee 2016[13](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-13) | GHK joined to 5-aminolevulinic acid, no copper, on the scalp | 45 men with pattern hair loss, 6 months, vs placebo | Hair count rose more than on placebo; no difference in thickness or length |
| Kapoor 2018[14](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-14) | Scalp injections of six growth factors and peptides, copper tripeptide-1 among them | 1,000 patients, no control group | Less shedding and more hair; GHK-Cu's share can't be separated |
| Liu 2023[12](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-12) | 2% GHK-Cu in a microemulsion vs 5% minoxidil vs saline | Shaved healthy mice, 6 per group, 21 days | The authors report regrowth beyond minoxidil's |
| Uno and Kurata 1993[11](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-11) | PC1031, a synthetic copper-binding peptide, not GHK-Cu | Fuzzy rats | Larger follicles, an effect the authors likened to topical minoxidil's |
| Pyo 2007[10](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-10) | AHK-Cu, a related copper tripeptide | Human scalp follicles and papilla cells in a dish | Follicles grew longer; papilla cells multiplied |

The eyebrow trial is well designed, randomized and double-blind (pepvault.app/glossary/double-blind) with one brow as the other's control, but it had 18 people, appeared in conference proceedings PubMed does not index, and treated brows, not a thinning scalp[15](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-15). A 2026 systematic review of GHK-Cu on its own in aesthetic medicine found 20 studies, 18 of them preclinical, and only 2 randomized trials, both on skin[16](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-16). A second 2026 review, of peptide products for hair loss in people, found 14 trials and rated formulas containing GHK, combinations with other peptides among them, at grade B on an A-to-C scale[22](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-22).

Species note: the Liu, Uno and Pyo results are from mice, rats (pepvault.app/glossary/in-vivo) and human tissue in a dish (pepvault.app/glossary/in-vitro): copper peptides acting on follicles, not a serum regrowing a person's hair.

## Has anyone tested GHK-Cu against minoxidil?

Not in people. The one direct comparison is in mice: in shaved mice, 6 per group, a 2% GHK-Cu microemulsion regrew more fur than 5% minoxidil over 21 days, by the authors' account[12](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-12). Shaved healthy mice are a model of regrowth after shaving, not of pattern hair loss.

A claim circulates online that a 2022 study found a 0.5% GHK-Cu serum raised hair count 22% in 16 weeks and beat 3% minoxidil; other pages cite a 2006 trial and a 2023 trial of 114 people. On November 20, 2026 we searched PubMed and ClinicalTrials.gov for GHK-Cu and copper peptides in hair loss and found none of them. Until a paper can be read, those numbers have no source.

## What about oral minoxidil?

Low-dose oral minoxidil is off-label (pepvault.app/glossary/off-label): a doctor prescribes a tablet approved only for severe high blood pressure, at a usual 10 to 40 mg a day, with a boxed warning (pepvault.app/glossary/boxed-warning) written for those patients[20](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-20). The hair studies use lower amounts: the men's trial below tested 5 mg a day.

The trials so far put it level with topical. In a 24-week randomized trial in 90 men, 5 mg by mouth daily did not beat 5% topical twice daily on hair density[17](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-17). A 2025 meta-analysis (pepvault.app/glossary/meta-analysis) of four randomized trials and 279 patients found the same hair density and thickness on oral and topical, with extra body and facial hair about twice as common on oral[18](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-18). In the largest safety study, 1,404 patients, 15.1% had extra hair growth, 1.7% lightheadedness and 1.3% fluid retention; 1.7% stopped over a side effect[19](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-19).

In 2025, 43 hair-loss dermatologists from 12 countries agreed on who suits it and what to check first[21](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-21). It is a decision made with a doctor, and no trial has compared it with GHK-Cu.

## What side effects does each one have?

On the scalp, minoxidil's usual effects are itching and irritation, a little more often on 5% than on 2%[1](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-1) [2](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-2). In women on 5%, extra hair outside the scalp (hypertrichosis) was more common than on 2% or placebo[2](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-2). In the eyebrow trial, GHK-Cu caused no serious side effects or allergic reactions, and the 2016 scalp trial of GHK with 5-aminolevulinic acid recorded no adverse events[13](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-13) [15](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-15).

**Commonly reported:** a few weeks of extra shedding in the first two months of minoxidil, which users describe as settling; an itchy or flaky scalp on solutions; a faint blue tint and occasional mild tingling from GHK-Cu serums.

**When to get help** The minoxidil labels say to stop and ask a doctor if chest pain, a racing heartbeat, faintness or dizziness, sudden weight gain, or swollen hands or feet appear[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7).

## Can you use GHK-Cu and minoxidil together?

No trial has tested the pairing. The minoxidil labels say not to use it if you use other medicines on the scalp[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7); a cosmetic serum isn't a medicine, and a pharmacist can say whether a particular product counts.

## How do you tell if it's working?

1. Before the first use, photograph the top and the parting in the same light and angle, hair dry and combed the same way.
2. Write down the start date, the product and its strength.
3. Use it the same way every day; the labels say regrowth only lasts with continued use[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6).
4. Compare new photos with the first ones at month 2 and month 4 (month 3 and month 6 on the women's foam), the points the labels name[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7).
5. If there is no regrowth by month 4 on the men's products or month 6 on the women's foam, the labels say to stop and ask a doctor[6](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-6) [7](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair#source-7).

Photo days line up with the labels' checkpoints; before them, no change is expected.

<!--promo-->

PepVault's side-effects log keeps each entry with its date, severity and a note, so an itchy week or a shedding phase sits on the calendar beside your start date. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-ghk-cu-vs-minoxidil-for-hair-inlin&mt=8)

<!--/promo-->

## Where to read more

- The GHK-Cu library page, pepvault.app/peptides/ghk-cu, with its side effects, how long it takes to work and legal status pages.
- Study pages for GHK-Cu, from pepvault.app/research/ghk-cu-maquart-1993 to pepvault.app/research/ghk-cu-mokhtar-2026.
- Peptides for skin, side by side: pepvault.app/peptides/for/skin.
- Next guide: GHK-Cu for skin and hair, what's measured.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Olsen EA et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002. [PubMed 12196747](https://pubmed.ncbi.nlm.nih.gov/12196747/)
2. Lucky AW et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004. [PubMed 15034503](https://pubmed.ncbi.nlm.nih.gov/15034503/)
3. Olsen EA et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007. [PubMed 17761356](https://pubmed.ncbi.nlm.nih.gov/17761356/)
4. Bergfeld W et al. A phase III, multicenter, parallel-design clinical trial to compare the efficacy and safety of 5% minoxidil foam versus vehicle in women with female pattern hair loss. J Drugs Dermatol. 2016. [PubMed 27391639](https://pubmed.ncbi.nlm.nih.gov/27391639/)
5. Blume-Peytavi U et al. Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss: a phase III, randomized, investigator-blinded study. J Drugs Dermatol. 2016. [PubMed 27391640](https://pubmed.ncbi.nlm.nih.gov/27391640/)
6. DailyMed. Men's Rogaine Extra Strength (minoxidil 5%) topical solution, drug facts label (Kenvue, Nov 2026). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ccaecec5-5348-4b24-9190-5464c50f6d80)
7. DailyMed. Women's Rogaine (minoxidil 5%) topical foam, drug facts label (Nov 2024). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d328537-b7f5-43cc-9837-c5a0c6c390f8)
8. DailyMed. Women's Rogaine (minoxidil 2%) topical solution, drug facts label (Sep 2024). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf0000c-95f3-4a4d-830b-f5ac1539823d)
9. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004. [PubMed 14996087](https://pubmed.ncbi.nlm.nih.gov/14996087/)
10. Pyo HK et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007. [PubMed 17703734](https://pubmed.ncbi.nlm.nih.gov/17703734/)
11. Uno H, Kurata S. Chemical agents and peptides affect hair growth. J Invest Dermatol. 1993. [PubMed 8326148](https://pubmed.ncbi.nlm.nih.gov/8326148/)
12. Liu T et al. Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application. Bioact Mater. 2023. [PubMed 38026438](https://pubmed.ncbi.nlm.nih.gov/38026438/)
13. Lee WJ et al. Efficacy of a complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide on hair growth. Ann Dermatol. 2016. [PubMed 27489425](https://pubmed.ncbi.nlm.nih.gov/27489425/)
14. Kapoor R, Shome D. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth: safety and efficacy evaluation in a first-in-man pilot clinical study. J Cosmet Laser Ther. 2018. [PubMed 29482481](https://pubmed.ncbi.nlm.nih.gov/29482481/)
15. Bo SL et al. The efficacy of 2% copper peptide (GHK-Cu) serum for eyebrow hypotrichosis: a randomized, double-blind, vehicle-controlled, split-face comparative study. Procedia of Multidisciplinary Research. 2026;4(5). [so09.tci-thaijo.org](https://so09.tci-thaijo.org/index.php/PMR/article/view/9318)
16. Mokhtar J et al. The regenerative potential of GHK-Cu in aesthetic medicine. Aesthet Surg J. 2026. [PubMed 42619529](https://pubmed.ncbi.nlm.nih.gov/42619529/)
17. Penha MA et al. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol. 2024. [PubMed 38598226](https://pubmed.ncbi.nlm.nih.gov/38598226/)
18. Sobral MVS et al. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. Int J Dermatol. 2025. [PubMed 39425514](https://pubmed.ncbi.nlm.nih.gov/39425514/)
19. Vañó-Galván S et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021. [PubMed 33639244](https://pubmed.ncbi.nlm.nih.gov/33639244/)
20. DailyMed. Minoxidil tablets, prescribing information (American Health Packaging, Aug 2026). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b4fc036-9497-442b-b629-c4b386932789)
21. Akiska YM et al. Low-dose oral minoxidil initiation for patients with hair loss: an international modified Delphi consensus statement. JAMA Dermatol. 2025. [PubMed 39565602](https://pubmed.ncbi.nlm.nih.gov/39565602/)
22. Joerg L, Zafar K, Jagdeo J. Peptides for hair growth and treatment of hair loss and alopecia: a systematic review. J Drugs Dermatol. 2026. [PubMed 42976838](https://pubmed.ncbi.nlm.nih.gov/42976838/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · Skin and longevity

Guide · Skin and longevity

### [GHK-Cu injection vs topical: what the studies show](https://pepvault.app/guides/ghk-cu-injection-vs-topical)

GHK-Cu's studies split by route: what serums, gels and microneedling measured in people, what injection measured in animals, and why FDA splits it too.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [GHK-Cu Studied range: 1–2 mg](https://pepvault.app/peptides/ghk-cu)

## Related guides

- Guide · Recovery

  ### [GHK-Cu for skin and hair: what's measured](https://pepvault.app/guides/ghk-cu-skin-and-hair)

  What GHK-Cu has shown in people for skin and hair: the serum and laser trials, the hair studies, what is lab-only, and what injecting it has never tested.

  Read the guide
- Guide · The science

  ### [Melanotan 1 vs 2: what each one does](https://pepvault.app/guides/melanotan-1-vs-melanotan-2)

  Melanotan 1 is afamelanotide, approved as Scenesse for EPP; melanotan 2 is unapproved. What each does, what trials measured, and how moles change.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### GHK-Cu

- [GHK-Cu: the full reference](https://pepvault.app/peptides/ghk-cu)
- [GHK-Cu dose guide](https://pepvault.app/lab/dosage/ghk-cu)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ghk-cu-10mg)
- [50 mg vial](https://pepvault.app/tools/reconstitution-calculator/ghk-cu-50mg)
- [100 mg vial](https://pepvault.app/tools/reconstitution-calculator/ghk-cu-100mg)

### Studies

- [GHK-Cu: no faster redness fading after CO2 laser skin resurfacing](https://pepvault.app/research/ghk-cu-miller-2006)
- [GHK-Cu gel: 98.5% median closure of diabetic plantar ulcers vs 60.8%](https://pepvault.app/research/ghk-cu-mulder-1994)
- [GHK-Cu: review of 20 studies finds skin repair signals, few trials](https://pepvault.app/research/ghk-cu-mokhtar-2026)
- [All 11 studies](https://pepvault.app/research#ghk-cu)

### Compared with

- [GHK-Cu vs BPC-157](https://pepvault.app/peptides/compare/ghk-cu-vs-bpc-157)
- [TB-500 vs GHK-Cu](https://pepvault.app/peptides/compare/tb-500-vs-ghk-cu)
- [GHK-Cu vs KPV](https://pepvault.app/peptides/compare/ghk-cu-vs-kpv)
- [GHK-Cu vs SNAP-8](https://pepvault.app/peptides/compare/ghk-cu-vs-snap-8)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Skin and longevity path

- [GHK-Cu for skin and hair: what's measured](https://pepvault.app/guides/ghk-cu-skin-and-hair)
- [Melanotan 1 vs 2: what each one does](https://pepvault.app/guides/melanotan-1-vs-melanotan-2)
- [What is Cerebrolysin? The trial evidence](https://pepvault.app/guides/cerebrolysin-explained)
- [Khavinson bioregulators, explained](https://pepvault.app/guides/khavinson-bioregulators-explained)
- [SS-31 (elamipretide): what the trials show](https://pepvault.app/guides/ss-31-elamipretide)
- [MOTS-c: the mouse and human studies](https://pepvault.app/guides/mots-c-studies)
- [SS-31 vs MOTS-c: where each works and what the human data show](https://pepvault.app/guides/ss-31-vs-mots-c)
- [Are collagen peptides the same as research peptides?](https://pepvault.app/guides/collagen-vs-research-peptides)
- [GHK-Cu injection vs topical: what the studies show](https://pepvault.app/guides/ghk-cu-injection-vs-topical)
- [Thymulin vs Thymalin: what's the difference?](https://pepvault.app/guides/thymulin-vs-thymalin)
- [Semax and Selank: what the studies found](https://pepvault.app/guides/semax-and-selank)
- [PT-141 (bremelanotide) for women and men: what the trials measured](https://pepvault.app/guides/pt-141-bremelanotide)
- [PT-141 nasal spray: does it work?](https://pepvault.app/guides/pt-141-nasal-spray)
- [How to reconstitute NAD+, and how often the studies gave it](https://pepvault.app/guides/nad-plus-mixing-and-how-often)
- [The FDA peptide panel explained: both meetings and what each vote means](https://pepvault.app/guides/fda-peptide-panel-explained)
- [Low-dose naltrexone (LDN): what it's used for and what the trials show](https://pepvault.app/guides/low-dose-naltrexone)
- [Is low-dose naltrexone (LDN) safe in pregnancy, and before trying to conceive?](https://pepvault.app/guides/ldn-and-pregnancy)
- [Do you stop low-dose naltrexone (LDN) before surgery or a colonoscopy?](https://pepvault.app/guides/ldn-before-surgery)
- [Does minoxidil cause hair loss?](https://pepvault.app/guides/minoxidil-shedding)
- [Can you take minoxidil with finasteride?](https://pepvault.app/guides/minoxidil-with-finasteride)
- [Peptides for hair growth: what the studies show](https://pepvault.app/guides/peptides-for-hair-growth)
- [Peptides for skin: what the human studies show](https://pepvault.app/guides/peptides-for-skin)
- [Do tanning peptides protect you from the sun?](https://pepvault.app/guides/tanning-peptides-and-the-sun)
- [Tretinoin vs retinol vs GHK-Cu for skin](https://pepvault.app/guides/tretinoin-vs-retinol-vs-ghk-cu)
- [Epitalon and telomeres: what was measured](https://pepvault.app/guides/epitalon-and-telomeres)
- [Dihexa: what is known, and what is not](https://pepvault.app/guides/dihexa-what-is-known)
- [Does Pinealon help sleep, and why does it make some people sleepy?](https://pepvault.app/guides/pinealon-and-sleep)
- [Selank vs oxytocin for anxiety: what the trials found](https://pepvault.app/guides/selank-vs-oxytocin-for-anxiety)
- [Oxytocin nasal spray: what it is used for](https://pepvault.app/guides/oxytocin-nasal-spray)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Cycle](https://pepvault.app/glossary/cycle)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Boxed warning](https://pepvault.app/glossary/boxed-warning)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
